Correlation Between GlaxoSmithKline PLC and BMO MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and BMO MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and BMO MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and BMO MSCI All, you can compare the effects of market volatilities on GlaxoSmithKline PLC and BMO MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of BMO MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and BMO MSCI.

Diversification Opportunities for GlaxoSmithKline PLC and BMO MSCI

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and BMO is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and BMO MSCI All in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BMO MSCI All and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with BMO MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BMO MSCI All has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and BMO MSCI go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and BMO MSCI

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the BMO MSCI. In addition to that, GlaxoSmithKline PLC is 2.3 times more volatile than BMO MSCI All. It trades about -0.24 of its total potential returns per unit of risk. BMO MSCI All is currently generating about 0.13 per unit of volatility. If you would invest  6,822  in BMO MSCI All on August 28, 2024 and sell it today you would earn a total of  245.00  from holding BMO MSCI All or generate 3.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy97.67%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  BMO MSCI All

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
BMO MSCI All 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BMO MSCI All are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, BMO MSCI is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and BMO MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and BMO MSCI

The main advantage of trading using opposite GlaxoSmithKline PLC and BMO MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, BMO MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BMO MSCI will offset losses from the drop in BMO MSCI's long position.
The idea behind GlaxoSmithKline PLC ADR and BMO MSCI All pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume